Prospective, unmasked evaluation of the iStent® Inject system for open-angle glaucoma: Synergy trial

Advances in Therapy

Volumn 31, Issue 2, 2014, Pages 189-201

  Voskanyan, Lilit ^a   García Feijoó, Julián ^b,c   Belda, Jose I ^d,e   Fea, Antonio ^f   Jünemann, Anselm ^g   Baudouin, Christophe ^h  

^a SVMalayan's Ophthalmologic Center   (Armenia)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d HOSPITAL DE TORREVIEJA   (Spain)

^e Glaucoma Unit Clinica Oftalica   (Spain)

^f UNIVERSITY OF TURIN   (Italy)

^g UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^h CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

Author keywords

Ab interno; Intraocular pressure; iStent inject; Open angle glaucoma; Ophthalmology; Trabecular bypass

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBONATE DEHYDRATASE INHIBITOR; PROSTAGLANDIN DERIVATIVE;

AB INTERNO TRABECULAR MICRO BYPASS STENT; ADULT; AGED; ARTICLE; EVALUATION STUDY; FEMALE; GLAUCOMA SURGERY; HUMAN; IMPLANTATION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MICRO INVASIVE GLAUCOMA SURGERY; MULTICENTER STUDY; OPEN ANGLE GLAUCOMA; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; STENT; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; COHORT STUDIES; FEMALE; GLAUCOMA DRAINAGE IMPLANTS; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRABECULECTOMY; TREATMENT OUTCOME;

EID: 84899119165     PISSN: 0741238X     EISSN: 18658652     Source Type: Journal    
DOI: 10.1007/s12325-014-0095-y     Document Type: Article

References (19)

1. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82:844-51. (Pubitemid 39573742)
2. American Academy of Ophthalmology Glaucoma Panel. Preferred Practice Pattern® guidelines. Primary open-angle glaucoma. San Francisco, CA: American Academy of Ophthalmology; 2010. Available at: http://www.aao.org/ppp. Last accessed January 6, 2014.
3. Samuelson TW, Katz LJ, Wells JM, Duh Y-J, Giamporcaro JE, for the US iStent Study Group. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology. 2011;118:459-67.
4. Fea AM. Phacoemulsification versus phacoemulsification with micro-bypass stent implantation in primary open-angle glaucoma. J Cataract Refract Surg. 2010;36:407-12.
5. Craven ER, Katz LJ, Wells JM, Giamporcaro JE, for the iStent Study Group. Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: Two-year follow-up. J Cataract Refract Surg. 2012;38:1339-45.
6. Grant WM. Experimental aqueous perfusion in enucleated human eyes. Arch Ophthalmol. 1963;69:783-801.
7. Johnstone MA, Grant WG. Pressure-dependent changes in structures of the aqueous outflow system of human and monkey eyes. Am J Ophthalmol. 1973;75:365-83.
8. Rosenquist R, Epstein D, Melamed S, et al. Outflow resistance of enucleated human eyes at two different perfusion pressures and different extents of trabeculotomy. Curr Eye Res. 1989;8:1233-40. (Pubitemid 20090355)
9. Saheb H, Ahmed II. Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol. 2012;23:96-104.
10. Arriola-Villalobos P, Martinez-de-la-Casa J, Fernandez-Perez J, et al. Combined iStent trabecular micro-bypass stent implantation and phacoemulsification for coexistent open-angle glaucoma and cataract: a long-term study. Br J Ophthalmol. 2012;. doi:10.1136/bjophthalmol-2011-300218.
11. Spiegel D, Wetzel W, Neuhann T, et al. Coexistent primary open-angle glaucoma and cataract: interim analysis of a trabecular micro-bypass stent and concurrent cataract surgery. Eur J Ophthalmol. 2009;19:393-9.
12. Fea AM, Pignata, G, Bartoli E, et al. Prospective, randomized, double-masked trial of trabecular bypass stent and cataract surgery vs. cataract surgery alone in primary OAG: long-term data. Presented at the 2012 European Society of Cataract and Refractive Surgeons, Milan, Italy, September, 2012.
13. Bahler C, Hann C, Fjield T, et al. Second-generation trabecular meshwork bypass stent (iStent inject) increases outflow facility in cultured human anterior segments. Am J Ophthal. 2012;153:1206-13.
14. Bahler C, Smedley G, Zhou J, Johnson D. Trabecular bypass stents decrease intraocular pressure in cultured human anterior segments. Am J Ophthal. 2004;138:988-94. (Pubitemid 40040014)
15. Early Treatment Diabetic Retinopathy Study. Manual of operations. Chap. 12, 1985.
16. Arriola-Villalobos P, Martinez de la Casa JM, Diaz-Valle D, et al. Mid-term evaluation of the new Glaukos iStent with phacoemulsification in coexistent open-angle glaucoma or ocular hypertension and cataract. Br J Ophthalmol. 2013;97:1250-5.
17. Belovay GW, Naqi A, Chan BJ, Rateb M, Ahmed II. Using multiple trabecular micro-bypass stents in cataract patients to treat open-angle glaucoma. J Cataract Refract Surg. 2012;38:1911-7.
18. Katz LJ, on behalf of the MIGS Study Group. IOP and medication reduction after micro invasive glaucoma surgery with two trabecular micro-bypass stents in OAG. Presented at 2013 American Glaucoma Society Annual Meeting, San Francisco, CA, February, 2013.
19. Chang LJ, on behalf of the MIGS Study Group. Intraocular pressure reduction and safety outcomes after microinvasive glaucoma surgery with 2 trabecular bypass stents in OAG. Presented at 2013 American Society of Cataract and Refractive Surgeons Annual Meeting, San Francisco, CA, April, 2013.